U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342062) titled 'Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State' on Jan. 06.
Brief Summary: This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fed state.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: DA-1229_01
single dose administration (DA-1229 one tablet once a day)
DRUG: DA-1229_01-R
single dose administration (DA-1229\_01-R one tablet once a day)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Dong-A ST Co., Ltd.
Disclaimer: Curated by HT Syndication....